| 2007 |
|
2007 January-February
|
Vol. 24,
No. 1 |
Blair P. Wilbert, Pharm. D. |
| Update on New Drugs of 2005-2006 |
| 2006 |
| 2006 September-October |
Vol. 23
No. 4 |
Laurel L. Andrews, Pharm.D.; W. Greg Leader, Pharm.D. |
| An Overview of Second Generation Antihistamines. |
| 2006 May-June |
Vol. 23
No. 3 |
Bill Ross, BS Pharm.; Gregory W. Smith, R. Ph., |
| Asthma in Exercise and Sports |
| 2006 March-April |
Vol. 23,
No. 2 |
Kelli Sorrells, Pharm.D. |
| Identifying the Risks Associated with Nonsteroidal Anti-Inflammatory Drugs and Heart Failure |
| 2006 January-February |
Vol. 23,
No. 1 |
Bill Ross; Charles N. Bell, Jr. R.Ph. |
| Risks Associated with Inhaled Corticosteroid Therapy and The Role of the Peak Flow Meter in the Management of Asthma |
| 2005 |
| 2005 Winter |
Vol. 22,
No. 4 |
Lezly A. Boudreaux, Pharm.D. Candidate; Shanna M. Thibodeaux, Pharm. D. |
| A Review of Osteoporosis |
| 2005 Summer |
Vol. 22,
No. 3 |
Corbin Turpin, M.D.; Melissa L. Dear, R. Ph.; Pam Walters, R. Ph. |
| Polypharmacy: Consequences and Management |
| 2005 March-April |
Vol. 22,
No. 2 |
Evangeline Ward, BS Pharm. |
| The Importance of Folic Acid in Preganancy |
| 2005 January-February |
Vol. 22,
No. 1 |
Melissa L. Dear, BS Pharm. |
| Inappropriate Prescribing in the Elderly |
|
|
| 2004 |
| 2004 November-December |
Vol. 21,
No. 6 |
W. Greg Leader, Pharm.D. |
| Chronic Obstructive Pulmonary Disease (COPD) |
| 2004 September-October |
Vol. 21,
No. 5 |
W. Greg Leader, Pharm.D., Anand Dalal, Ph.D. Candidate |
| Hepatitis C Treatment and Monitoring |
| 2004 July-August |
Vol. 21,
No. 4 |
W. Greg Leader, Pharm.D., Anand Dalal, Ph.D. Candidate |
| Hepatitis C Testing and Prevalence |
| 2004 May-June |
Vol. 21,
No. 3 |
Gina C. Biglane, Pharm.D. |
| Issues in Pain Management |
| 2004 March-April |
Vol. 21,
No. 2 |
Lisa Digioia-Ross, Pharm.D.; Robert D. Ross, M.D., FACS |
| Age-Related Macular Degeneration: Past, Present & Future |
| 2004 January-February |
Vol. 21,
No. 1 |
Melissa L. Dear, BS Pharm. |
| Inappropriate Prescribing in the Elderly |
|
|
| 2003 |
| 2003 August-October |
Vol. 20,
No. 4 |
Martin B. Steffenson, Pharm.D.; Summer C. Helo, Pharm.D. Candidate; September E. Lee, Pharm.D. Candidate; Michael S. D. Huynh, Pharm.D. Candidate |
| Low Molecular Weight Heparin in the Treatment of Deep Vein Thrombosis: Briding the Gap to Better Outcomes |
| 2003 June-July |
Vol. 20,
No. 3 |
Bill Ross, BS Pharm. |
| Glucocorticosteroids and Osteoporosis |
| 2003 April-May |
Vol. 20,
No. 2 |
Larry J. Humble, R. Ph.; Gina C. Biglane, Pharm.D.; Sandra G. Blake, Ph.D. |
| Attention Deficit Hyperactivity Disorder (ADHD) in the Louisiana Medicaid Population: Prevalence, Demographic, and Clinical Characteristics |
| 2003 February-March |
Vol. 20,
No. 1 |
W. Greg Leader, Pharm.D. |
| Guidelines for the Treatment of High Cholesterol: A Review |
| 2002 |
| 2002 December-2003 January |
Vol. 19,
No. 6 |
Nicole Robin Krohn, Pharm.D. |
| New Oral Pharmacologic Options in the Treatment of Overactive Bladder: Focus on the Antimuscarinic Agents |
| 2002 October-November |
Vol. 19,
No. 5 |
Charles W. Jastram, Jr., Pharm.D. |
| Vitamin Use in Adults |
| 2002 August-September |
Vol. 19,
No. 4 |
Ahmad Khalil, Pharm.D.; C. David Matthews, Pharm.D. |
| Pediatric Drug Dosing |
| 2002 June-July |
Vol. 19,
No. 3 |
Justin J. Sherman, Pharm.D. |
| Treating Hypertension in the Patient with Diabetes: Revised Goals & Medication Management |
| 2002 April-May |
Vol. 19,
No. 2 |
Lesa W. Lawrence, Ph.D. |
| Who Defines "Quality of Life?" |
| 2002 February-March |
Vol. 19,
No. 1 |
Sandra G. Blake, Ph.D. |
| An Introduction to Pharmacoeconomics |
|
|
| 2001 |
| 2001 December-2002 January |
Vol. 18,
No. 6 |
Lisa M. Digioia-Ross, Pharm.D. |
| Glaucoma 2001: An Overview with Emphasis on Medical Management |
| 2001 October-November |
Vol. 18,
No. 5 |
J. Lance Nickelson, Pharm.D. |
| Selection of Antipsychotics in the Elderly: A Focus on the Atypical Antipsychotics |
| 2001 August-September |
Vol. 18,
No. 4 |
Mark Ryan, R.Ph, CSPI |
| Acetaminophen Toxicity |
| 2001 June-July |
Vol. 18,
No. 3 |
W. Greg Leader, Pharm.D. |
| Hepatitis C: The Silent Killer |
| 2001 April-May |
Vol. 18,
No. 2 |
Nancy M. Toedter, Pharm.D. |
| Treatment of HIV Infection: An Overview - Part II |
| 2001 February-March |
Vol. 18,
No. 1 |
Nancy M. Toedter, Pharm.D. |
| Treatment of HIV Infection: An Overview - Part I |
|
|
| 2000 |
| 2000 December-2001 January |
Vol. 17,
No. 6 |
Shanna Thibodeaux, Pharm.D. |
| Appropriate Use of Prescription Antisecretory Agents in Acid-Related Diseases |
| 2000 October-November |
Vol. 17,
No. 5 |
Cathy Whipple, R.Ph. |
| Acute Otitis Media: Management and Prevention of Resistance |
| 2000 August-September |
Vol. 17,
No. 4 |
J. Christopher Lynch, Pharm.D. |
| Cardiovascular Disease in Women |
| 2000 June-July |
Vol. 17,
No. 3 |
Martin B. Steffenson, Pharm.D.; Siddarthan IIangovan, M. Pharm. |
| Smoking Cessation: Basic Strategies to Foster and Assist Patients to Stop Smoking Tobacco |
| 2000 April-May |
Vol. 17,
No. 2 |
No provider Update Article in this Issue |
| 2000 February-March |
Vol. 17,
No. 1 |
Nancy M. Toedter, Pharm.D. |
| Urinary Tract Infections |
| 1999 December-2000 January |
Vol. 16,
No. 6 |
Shatha A. Al-Samarrai, Pharm.D., W. Greg Leader, Pharm.D. |
| Appropriate Use of H2-Antagonists and Proton Pump Inhibitors for Managing Gastrointestinal Disorders |
